학술논문
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Document Type
article
Author
Pagano, Livio; Salmanton-García, Jon; Marchesi, Francesco; Busca, Alessandro; Corradini, Paolo; Hoenigl, Martin; Klimko, Nikolai; Koehler, Philipp; Pagliuca, Antonio; Passamonti, Francesco; Verga, Luisa; Víšek, Benjamin; Ilhan, Osman; Nadali, Gianpaolo; Weinbergerová, Barbora; Córdoba-Mascuñano, Raúl; Marchetti, Monia; Collins, Graham P; Farina, Francesca; Cattaneo, Chiara; Cabirta, Alba; Gomes-Silva, Maria; Itri, Federico; van Doesum, Jaap; Ledoux, Marie-Pierre; Čerňan, Martin; Jakšić, Ozren; Duarte, Rafael F; Magliano, Gabriele; Omrani, Ali S; Fracchiolla, Nicola S; Kulasekararaj, Austin; Valković, Toni; Poulsen, Christian Bjørn; Machado, Marina; Glenthøj, Andreas; Stoma, Igor; Ráčil, Zdeněk; Piukovics, Klára; Navrátil, Milan; Emarah, Ziad; Sili, Uluhan; Maertens, Johan; Blennow, Ola; Bergantim, Rui; García-Vidal, Carolina; Prezioso, Lucia; Guidetti, Anna; del Principe, Maria Ilaria; Popova, Marina; de Jonge, Nick; Ormazabal-Vélez, Irati; Fernández, Noemí; Falces-Romero, Iker; Cuccaro, Annarosa; Meers, Stef; Buquicchio, Caterina; Antić, Darko; Al-Khabori, Murtadha; García-Sanz, Ramón; Biernat, Monika M; Tisi, Maria Chiara; Sal, Ertan; Rahimli, Laman; Čolović, Natasa; Schönlein, Martin; Calbacho, Maria; Tascini, Carlo; Miranda-Castillo, Carolina; Khanna, Nina; Méndez, Gustavo-Adolfo; Petzer, Verena; Novák, Jan; Besson, Caroline; Duléry, Rémy; Lamure, Sylvain; Nucci, Marcio; Zambrotta, Giovanni; Žák, Pavel; Seval, Guldane Cengiz; Bonuomo, Valentina; Mayer, Jiří; López-García, Alberto; Sacchi, Maria Vittoria; Booth, Stephen; Ciceri, Fabio; Oberti, Margherita; Salvini, Marco; Izuzquiza, Macarena; Nunes-Rodrigues, Raquel; Ammatuna, Emanuele; Obr, Aleš; Herbrecht, Raoul; Núñez-Martín-Buitrago, Lucía; Mancini, Valentina; Shwaylia, Hawraa; Sciumè, Mariarita; Essame, Jenna; Nygaard, Marietta; Batinić, Josip
Source
Journal of Hematology & Oncology. 14(1)
Subject
Language
Abstract
BackgroundPatients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-19 and analyzed predictors of mortality.MethodsThe survey was supported by the Scientific Working Group Infection in Hematology of the European Hematology Association (EHA). Eligible for the analysis were adult patients with HM and laboratory-confirmed COVID-19 observed between March and December 2020.ResultsThe study sample includes 3801 cases, represented by lymphoproliferative (mainly non-Hodgkin lymphoma n = 1084, myeloma n = 684 and chronic lymphoid leukemia n = 474) and myeloproliferative malignancies (mainly acute myeloid leukemia n = 497 and myelodysplastic syndromes n = 279). Severe/critical COVID-19 was observed in 63.8% of patients (n = 2425). Overall, 2778 (73.1%) of the patients were hospitalized, 689 (18.1%) of whom were admitted to intensive care units (ICUs). Overall, 1185 patients (31.2%) died. The primary cause of death was COVID-19 in 688 patients (58.1%), HM in 173 patients (14.6%), and a combination of both COVID-19 and progressing HM in 155 patients (13.1%). Highest mortality was observed in acute myeloid leukemia (199/497, 40%) and myelodysplastic syndromes (118/279, 42.3%). The mortality rate significantly decreased between the first COVID-19 wave (March-May 2020) and the second wave (October-December 2020) (581/1427, 40.7% vs. 439/1773, 24.8%, p value